
Trial launches of diagnostic agent for clear cell renal cell carcinoma
The first patient has been imaged in part D of a phase 1/2 trial (NCT05706129), evaluating the efficacy of the diagnostic agent ITM-94 (Debio 0328; [68Ga]Ga-DPI-4452) in detecting clear cell renal cell carcinoma (ccRCC) in patients with an …